“This repositioning will strengthen our focus on premium private-pay health care real estate, reinforce our industry-leading balance sheet strength, and enhance our operating and financial performance,” said
The pro forma impact of these transactions are expected to achieve several strategic benefits:
- Significant increase in private pay revenue mix to 92.4% from 89.4%
- Reduce long-term/post-acute care concentration to 13.5% from 19.9%
- Improve long-term/post-acute care payment coverage after management fees to 1.45x from 1.34x
- Further deleverage the balance sheet with undepreciated book capitalization moving to 34.4% from 39.5% and strengthening credit metrics
Dispositions Overview
We expect to execute on
In addition to the Genesis transactions described above, the company expects to realize value across other portfolios, capitalizing on the robust capital market conditions and increased domestic and foreign institutional investor interest in U.S. health care real estate. We anticipate approximately
Pro forma for the transactions, our long-term/post-acute care exposure will decrease from 19.9% to 13.5% and our Genesis concentration will decrease from 13.8% to 7.1%. We will also achieve significant balance sheet deleveraging, improved credit metrics and increased financial flexibility.
The tables below show estimated fourth quarter disposition guidance followed by projected use of proceeds (dollars in millions). Amounts, yields and timing are estimates and subject to change.
Disposition Proceeds | Estimated Amount | Effective Cap Rate(1) | |||||||||
Long-Term/Post-Acute Care (LT/PAC) | $ | 1,867 | 9.0 | % | |||||||
Seniors Housing Triple-Net (SH NNN) | 1,206 | 6.3 | % | ||||||||
Seniors Housing Operating (SHO) | 51 | 5.8 | % | ||||||||
Loans Receivable | 150 | 10.1 | % | ||||||||
Total | $ | 3,274 | 8.0 | % | |||||||
(1) Represents current annual cash NOI as a percentage of estimated proceeds. |
Use of Proceeds | Estimated Amount | Estimated Yield/Rate | ||||||||
4Q16 Acquisitions/Loans | $ | 314 | 7.2 | % | ||||||
4Q16 Development Funding | 156 | 8.0 | % | |||||||
Line of Credit Payoff | 1,350 |
1.4 |
% |
* |
||||||
2017 Senior Notes Payoff | 450 | 4.7 | % | |||||||
Secured Debt Payoffs | 668 | 5.4 | % | |||||||
Preferred Stock Redemption | 288 | 6.5 | % | |||||||
Debt Extinguishments and Other Costs | 48 | n/a | ||||||||
Total Uses | $ | 3,274 | ||||||||
* Rate as of 9/30/2016 | ||||||||||
Pro Forma Portfolio Metrics:
The dispositions are expected to have a significant positive impact on our private pay mix, LT/PAC payment coverage and tenant concentration, as shown in the table below. Please see the accompanying exhibits for In-Place Net Operating Income (IPNOI) reconciliations. The pro forma metrics are based on current expectations for dispositions and uses of proceeds described above which are subject to change.
Metrics | 3Q16 | Pro Forma | Change | |||||||||
Total Private Pay Revenue Mix % |
89.4 | % | 92.4 | % | 3.0 | % | ||||||
LT/PAC Payment Coverage after management fee | 1.34x | 1.45x | 0.11x | |||||||||
Genesis % of IPNOI | 13.8 | % | 7.1 | % | -6.7 | % | ||||||
LT/PAC % of IPNOI | 19.9 | % | 13.5 | % | -6.4 | % | ||||||
Pro Forma Credit Metrics:
The dispositions are expected to significantly improve all credit metrics, as shown in the table below. Please see the accompanying exhibits for reconciliations. The pro forma metrics are based on current expectations for dispositions and uses of proceeds described above which are subject to change.
Metrics | 3Q16 | Pro Forma | Change | ||||||||||||
Net Debt / Undepreciated Book Capitalization | 39.5 | % | 34.4 | % | -5.1 | % | |||||||||
Net Debt / Enterprise Value | 30.9 | % | 26.6 | % | -4.3 | % | |||||||||
Net Debt / Adjusted EBITDA | 5.7x | 5.1x | -0.6x | ||||||||||||
Secured Debt / Total Assets | 11.1 | % | 9.4 | % | -1.7 | % | |||||||||
Adjusted Interest Coverage | 4.3x | 4.4x | 0.1x | ||||||||||||
Adjusted Fixed Charge Coverage | 3.4x | 3.6x | 0.2x | ||||||||||||
Available Liquidity (millions)(1) | $ | 2,106 | $ | 3,456 | $ | 1,350 | |||||||||
(1) Represents line of credit availability plus unrestricted cash and IRC section 1031 deposits. |
|||||||||||||||
Additional 2017 Genesis Dispositions
In addition to the transactions described above, the company has entered into a memorandum of understanding with Genesis to exit certain states that Genesis considers non-core due to lack of scale and other strategic reasons. We expect to receive approximately
Management expects to further discuss the transactions described in this release on its earnings call on
- At the company’s website: www.welltower.com. To participate in the webcast, please log on 15 minutes in advance of the scheduled call to download the necessary software. A webcast replay will be available approximately two hours after the conference call concludes and will be available for 90 days.
- By telephone: The telephone dial-in number in the U.S. is 888-346-2469. For participants outside the U.S., the dial-in number is 706-758-4923. The conference ID number is 94724138.
A replay of the conference call will be available beginning at approximately
Supplemental Reporting Measures We believe that net income attributable to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), is the most appropriate earnings measurement. However, we consider in-place net operating income (IPNOI) and adjusted earnings before interest, taxes, depreciation and amortization (A-EBITDA) to be useful supplemental measures of our operating performance.
NOI is used to evaluate the operating performance of the company’s properties. The company defines NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our seniors housing operating and outpatient medical properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations or transaction costs. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. IPNOI represents NOI excluding interest income, other income and non-cash NOI and adjusted for timing of current quarter portfolio changes such as acquisitions, development conversions, segment transitions, dispositions and investments held for sale. This supplemental measure is disclosed on our pro rata ownership basis. Pro rata amounts are derived by reducing consolidated amounts for minority partners’ noncontrolling ownership interests and adding our minority ownership share of unconsolidated amounts. We does not control unconsolidated investments. While we consider pro rata disclosures useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution.
EBITDA stands for earnings (net income per income statement) before interest expense, income taxes, depreciation and amortization. Covenants in our primary unsecured credit facility and senior unsecured notes contain financial ratios based on a definition of EBITDA that is specific to those agreements. Failure to satisfy these covenants could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of these debt agreements and the financial covenants, we have defined A-EBITDA to include adjustments for stock-based compensation expense, provision for loan losses, gains/losses on extinguishment of debt, transactions costs, gains/losses/impairments on properties, gains/losses on derivatives and other non-recurring and/or non-cash income/charges. We believe that EBITDA and A-EBITDA, along with net income and cash flow provided from operating activities, are important supplemental measures because they provide additional information to assess and evaluate the performance of our operations. We primarily utilize them to measure our interest coverage ratio, which represents EBITDA and A-EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA and A-EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends.
The company’s supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. The company’s management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. A-EBITDA is also used to indicate our compliance with financial covenants in our primary unsecured credit facility and senior unsecured notes and is not being presented for use by investors for any other purpose. None of the supplemental reporting measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental reporting measures, as defined by the company, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
About
Forward-Looking Statements and Risk Factors This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When we use words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “pro forma,” “estimate” or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to our opportunities to acquire, develop or sell properties; our ability to close anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of our operators/tenants and properties; our expected occupancy rates; our ability to declare and to make distributions to shareholders; our investment and financing opportunities and plans; our continued qualification as a REIT; our ability to access capital markets or other sources of funds; and our ability to meet our earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause our actual results to differ materially from our expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; our ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting our properties; our ability to re-lease space at similar rates as vacancies occur; our ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting
Pro Forma In-Place Net Operating Income (IPNOI) Reconciliation |
Exhibit 1 | ||||||||||||||||
(In thousands at Welltower pro rata ownership) | |||||||||||||||||
3Q16 Actual(1) | Adjustments(2) | Pro Forma | |||||||||||||||
Annualized IPNOI: | |||||||||||||||||
Genesis long-term/post-acute care | $ | 288,541 | $ | (152,394 | ) | $ | 136,147 | ||||||||||
Other long-term/post-acute care | 129,251 | (3,037 | ) | 126,214 | |||||||||||||
Total long-term/post-acute care | 417,792 | (155,431 | ) | 262,361 | |||||||||||||
Genesis seniors housing triple-net | 745 | 745 | 1,490 | ||||||||||||||
All other | 1,682,139 | (2,293 | ) | 1,679,846 | |||||||||||||
Total annualized IPNOI | $ | 2,100,676 | $ | (156,979 | ) | $ | 1,943,697 | ||||||||||
Total quarterly IPNOI | 525,169 | ||||||||||||||||
IPNOI adjustments(3) | 70,339 | ||||||||||||||||
Pro rata NOI | 595,508 | ||||||||||||||||
Pro rata NOI adjustments(4) | 9,945 | ||||||||||||||||
Consolidated NOI(5) | $ | 605,453 | |||||||||||||||
% of annualized IPNOI: | |||||||||||||||||
Genesis % of IPNOI | 13.8 | % | -6.7 | % | 7.1 | % | |||||||||||
Total LTPAC % of IPNOI | 19.9 | % | -6.4 | % | 13.5 | % | |||||||||||
Notes: | |||||||||||||||||
(1) Please refer to Earnings Release and Supplemental Information reports issued November 2, 2016 for additional information. |
|||||||||||||||||
(2) Represents adjustments to reflect estimated 4Q16 dispositions and acquisitions described in this press release. |
|||||||||||||||||
(3) Includes interest income, other income, non-cash NOI, NOI for assets sold/held for sale and timing adjustments related to current quarter acquisitions, development conversions and segment transitions. |
|||||||||||||||||
(4) Represents NOI amounts attributable to joint venture partners, both majority and minority, net. |
|||||||||||||||||
(5) Represents total revenues less property operating expenses. |
|||||||||||||||||
Pro Forma Capitalization Reconciliations |
Exhibit 2 | ||||||||||||||||
(In thousands) | |||||||||||||||||
3Q16 Actual(1) | Adjustments(2) | Pro Forma | |||||||||||||||
Net Debt to Undepreciated Book Capitalization: | |||||||||||||||||
Line of credit | $ | 1,350,000 | $ | (1,350,000 | ) | $ | - | ||||||||||
Long-term debt obligations | 12,080,888 | (1,149,833 | ) | 10,931,055 | |||||||||||||
Cash and cash equivalents(3) | (456,420 | ) | - | (456,420 | ) | ||||||||||||
Net debt | $ | 12,974,468 | $ | (2,499,833 | ) | $ | 10,474,635 | ||||||||||
Accumulated depreciation and amortization | 4,243,038 | (280,438 | ) | 3,962,600 | |||||||||||||
Total equity(4) | 15,657,768 | 356,607 | 16,014,375 | ||||||||||||||
Undepreciated book capitalization | $ | 32,875,274 | $ | (2,423,664 | ) | $ | 30,451,610 | ||||||||||
Net debt to undepreciated book capitalization ratio | 39.5 | % | -5.1 | % | 34.4 | % | |||||||||||
Net Debt to Enterprise Value: | |||||||||||||||||
Net debt | $ | 12,974,468 | $ | (2,499,833 | ) | $ | 10,474,635 | ||||||||||
Common equity market capitalization(5) | 27,098,517 | - | 27,098,517 | ||||||||||||||
Preferred stock | 1,006,250 | (287,500 | ) | 718,750 | |||||||||||||
Noncontrolling interests(4) | 867,923 | 159,037 | 1,026,960 | ||||||||||||||
Enterprise value | $ | 41,947,158 | $ | (2,628,296 | ) | $ | 39,318,862 | ||||||||||
Net debt to enterprise value ratio | 30.9 | % | -4.3 | % | 26.6 | % | |||||||||||
Secured Debt to Total Assets: | |||||||||||||||||
Secured debt | $ | 3,317,933 | $ | (700,537 | ) | $ | 2,617,396 | ||||||||||
Total assets | $ |
29,856,339 |
$ | (2,087,895 | ) | $ |
27,768,444 |
||||||||||
Secured debt to total assets ratio | 11.1 | % | -1.7 | % | 9.4 | % | |||||||||||
Notes: | |||||||||||||||||
(1) Please refer to Earnings Release and Supplemental Information reports issued November 2, 2016 for additional information. |
|||||||||||||||||
(2) Represents adjustments to reflect all transactions related to estimated 4Q16 dispositions and uses of proceeds described in this press release. |
|||||||||||||||||
(3) Inclusive of IRC section 1031 deposits. |
|||||||||||||||||
(4) Includes all noncontrolling interests (redeemable and permanent). |
|||||||||||||||||
(5) Based on outstanding shares of 362,425,000 and $74.77 per share as of 9/30/16. |
|||||||||||||||||
Pro Forma Coverage Ratio Reconciliations |
Exhibit 3 | ||||||||||||||||
(In thousands) | |||||||||||||||||
3Q16 Actual(1) | Adjustments(2,3) | Pro Forma | |||||||||||||||
Net Debt to Adjusted EBITDA: | |||||||||||||||||
Net income | $ | 354,741 | $ | 453,269 | $ | 808,010 | |||||||||||
Interest expense | 129,699 | (20,283 | ) | 109,416 | |||||||||||||
Income tax expense (benefit) | (305 | ) | - | (305 | ) | ||||||||||||
Depreciation and amortization | 218,061 | (5,643 | ) | 212,418 | |||||||||||||
EBITDA | $ | 702,196 | $ | 427,343 | $ | 1,129,539 | |||||||||||
Transaction costs | 19,842 | - | 19,842 | ||||||||||||||
Stock-based compensation | 5,401 | - | 5,401 | ||||||||||||||
Loss/impairment (gain) on sales of properties, net | (152,646 | ) | (526,551 | ) | (679,197 | ) | |||||||||||
Loss (gain) on debt extinguishments, net | - | 41,481 | 41,481 | ||||||||||||||
Loss (gain) on derivatives, net | (2,516 | ) | - | (2,516 | ) | ||||||||||||
Adjusted EBITDA | $ | 572,277 | $ | (57,727 | ) | $ | 514,550 | ||||||||||
Adjusted EBITDA annualized | $ | 2,289,108 | $ | (230,908 | ) | $ | 2,058,200 | ||||||||||
Net debt(4) | $ | 12,974,468 | $ | (2,499,833 | ) | $ | 10,474,635 | ||||||||||
Net debt to adjusted EBITDA ratio | 5.7x | -0.6x | 5.1x | ||||||||||||||
Interest and Fixed Charge Coverage Ratios: | |||||||||||||||||
Interest expense | $ | 129,699 | $ | (20,283 | ) | $ | 109,416 | ||||||||||
Capitalized interest | 4,766 | 1,640 | 6,406 | ||||||||||||||
Non-cash interest | (543 | ) | 1,305 | 762 | |||||||||||||
Total interest | $ | 133,922 | $ | (17,338 | ) | $ | 116,584 | ||||||||||
Adjusted EBITDA | $ | 572,277 | $ | (57,727 | ) | $ | 514,550 | ||||||||||
Adjusted interest charge coverage ratio | 4.3x | 0.1x | 4.4x | ||||||||||||||
Total interest | $ | 133,922 | $ | (17,338 | ) | $ | 116,584 | ||||||||||
Secured debt principal amortizations | 18,151 | (3,671 | ) | 14,480 | |||||||||||||
Preferred dividends | 16,352 | (4,672 | ) | 11,680 | |||||||||||||
Total fixed charges | $ | 168,425 | $ | (25,681 | ) | $ | 142,744 | ||||||||||
Adjusted EBITDA | $ | 572,277 | $ | (57,727 | ) | $ | 514,550 | ||||||||||
Adjusted fixed charge coverage ratio | 3.4x | 0.2x | 3.6x | ||||||||||||||
Notes: | |||||||||||||||||
(1) Please refer to Earnings Release and Supplemental Information reports issued November 2, 2016 for additional information. |
|||||||||||||||||
(2) Includes adjustments to reflect all transactions related to estimated 4Q16 dispositions and uses of proceeds described in this press release. |
|||||||||||||||||
(3) Also includes adjustments to reflect a full quarter impact of the $1.15 billion 19-community seniors housing portfolio acquisition described in the company's Earnings Release dated November 2, 2016. |
|||||||||||||||||
(4) See Exhibit 2. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102005816/en/
Source:
Welltower Inc.
Scott Estes, 419-247-2800
or
Scott Brinker, 419-247-2800